Growth Hormone For Short Stature
The FDA has approved a supplemental New Drug Application for somatropin (of rDNA origin for injection) (Genotropin) to treat growth failure associated with Turner syndrome in patients whose bones are still capable of growing. The approval was based on two randomized, open-label, clinical trials in 38 children of short stature with Turner syndrome. Both studies [...]
Read User's Comments